The quantification showed that mRNA levels of all candidate genes were significantly higher in pancreatic cancer samples compared to controls (p < 0.0001 in FKBP1A, p < 0.0001 in PLD1, and p = 0.0002 in PSMA4). This evidence concerns the gene FKBP1A and pancreatic neoplasm.